A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial

Ebola viruses represent a class of filoviruses that causes severe hemorrhagic fever with high mortality. Recognized first in 1976 in the Democratic Republic of Congo, outbreaks continue to occur in equatorial Africa. A safe and effective Ebola virus vaccine is needed because of its continued emergen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Martin, Julie E., Sullivan, Nancy J., Enama, Mary E., Gordon, Ingelise J., Roederer, Mario, Koup, Richard A., Bailer, Robert T., Chakrabarti, Bimal K., Bailey, Michael A., Gomez, Phillip L., Andrews, Charla A., Moodie, Zoe, Gu, Lin, Stein, Judith A., Nabel, Gary J., Graham, Barney S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2006
Gaiak:
Vaccine Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1656552/
https://ncbi.nlm.nih.gov/pubmed/16988008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00162-06
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak